Parkside Investments’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.81M Buy
16,808
+2,280
+16% +$924K 0.93% 36
2025
Q1
$7.23M Buy
14,528
+161
+1% +$80.1K 1.06% 36
2024
Q4
$7.47M Sell
14,367
-4
-0% -$2.08K 1.12% 36
2024
Q3
$8.89M Buy
14,371
+198
+1% +$122K 1.34% 29
2024
Q2
$7.84M Sell
14,173
-15
-0.1% -$8.3K 1.24% 34
2024
Q1
$8.25M Sell
14,188
-69
-0.5% -$40.1K 1.31% 32
2023
Q4
$7.57M Buy
14,257
+390
+3% +$207K 1.28% 34
2023
Q3
$7.02M Buy
13,867
+385
+3% +$195K 1.29% 36
2023
Q2
$7.03M Sell
13,482
-145
-1% -$75.7K 1.31% 36
2023
Q1
$7.85M Buy
13,627
+400
+3% +$231K 1.48% 32
2022
Q4
$7.28M Buy
13,227
+736
+6% +$405K 1.45% 31
2022
Q3
$6.34M Buy
12,491
+3,980
+47% +$2.02M 1.36% 35
2022
Q2
$4.62M Buy
8,511
+963
+13% +$523K 0.97% 43
2022
Q1
$4.46M Buy
7,548
+161
+2% +$95.1K 0.87% 37
2021
Q4
$4.93M Buy
7,387
+170
+2% +$113K 0.95% 37
2021
Q3
$4.12M Sell
7,217
-2,970
-29% -$1.7M 0.86% 42
2021
Q2
$5.14M Buy
10,187
+240
+2% +$121K 0.99% 40
2021
Q1
$4.54M Buy
9,947
+260
+3% +$119K 0.94% 40
2020
Q4
$4.51M Buy
9,687
+601
+7% +$280K 1% 39
2020
Q3
$4.01M Sell
9,086
-2,237
-20% -$988K 1.05% 40
2020
Q2
$4.1M Buy
11,323
+300
+3% +$109K 1.08% 33
2020
Q1
$3.13M Sell
11,023
-1,960
-15% -$556K 1.03% 39
2019
Q4
$4.22M Sell
12,983
-720
-5% -$234K 1.02% 39
2019
Q3
$3.99M Sell
13,703
-910
-6% -$265K 1.07% 36
2019
Q2
$4.29M Sell
14,613
-405
-3% -$119K 1.12% 33
2019
Q1
$4.11M Buy
15,018
+819
+6% +$224K 1.12% 31
2018
Q4
$3.18M Buy
14,199
+5,050
+55% +$1.13M 1.38% 24
2018
Q3
$2.23M Sell
9,149
-450
-5% -$110K 1.06% 32
2018
Q2
$2.22M Sell
9,599
-2,285
-19% -$528K 1.09% 30
2018
Q1
$2.45M Sell
11,884
-5,400
-31% -$1.12M 1.28% 25
2017
Q4
$3.28M Sell
17,284
-850
-5% -$161K 1.6% 22
2017
Q3
$3.43M Sell
18,134
-2,936
-14% -$555K 1.98% 17
2017
Q2
$3.68M Sell
21,070
-375
-2% -$65.4K 2.29% 14
2017
Q1
$3.29M Buy
+21,445
New +$3.29M 2.32% 19